Ongoing Research Calls
The present study prioritizes withanolide F as a prospective COVID-19 (Coronavirus disease) therapeutic agent based on the observations. 1578 compounds fltered from 9596 phytochemicals were chosen for screening against the RBD of the native SARS-CoV-2 S protein. Based on the binding energy, Four phytochemicals, namely withanolide F, serotobenine, orobanchol, and gibberellin A51, were found to be potential RBD binders in native and all SARS-CoV-2 VOCs. Interestingly withanolide F exhibited lower binding energy (-10.84 to -8.56 kcal/mol) and better ligand efciency (-0.3 to -0.25) against all forms of RBD in native and VOCs.
NEW VICE CHANCELLOR ASSUMES OFFICE
Prof. Nihar Ranjan Biswas, Former Director and Vice Chancellor, Indira Gandhi Institute of Medical Sciences,
Celebration of One Health Day 2022 and Launch of One Health Initiative-Calling collaborations for actions
MGM Advanced Research Institute (MGMARI) in collaboration with Mahatma Gandhi Medical College & Research Institute